First-Line Treatment for Psoriasis in Adolescents

Topical Therapy Approach

The American Academy of Dermatology recommends applying high-potency topical corticosteroid (class 2-5) combined with calcipotriene/calcipotriol for initial control of psoriasis in adolescents 1, 2
The most common approach is to mix both medications 1:1 on the finger and apply together twice daily for the first 2 weeks, then transition to weekend-only corticosteroid application with weekday calcipotriol application to maintain remission while minimizing steroid exposure 1, 2
For facial and genital psoriasis, the American Academy of Dermatology recommends using tacrolimus 0.1% ointment as first-line monotherapy (off-label) to avoid skin atrophy risk from corticosteroids in sensitive areas 1, 2
For scalp psoriasis, the American Academy of Dermatology recommends using calcipotriol/betamethasone dipropionate suspension once daily for up to 8 weeks, which is specifically approved for ages 12 and older 4

The maximum calcipotriol dose is 50 g/week/m² to prevent hypercalcemia, and the maximum for combination scalp formulation is 80 g/week for adolescents 4
The American Academy of Dermatology recommends monitoring closely for HPA axis suppression with high-potency corticosteroids, though adolescents have a lower risk than younger children 1, 2

The American Academy of Dermatology recommends considering systemic therapy if body surface area involvement is >5%, there is an inadequate response to topical therapy after 4-8 weeks, or significant impact on quality of life despite topical treatment 3, 5, 6
First-line systemic options include UVB phototherapy (narrowband or broadband) as monotherapy, methotrexate (with or without UVB), adalimumab (approved for ages ≥4 years), etanercept (ages ≥6 years), and ustekinumab (ages ≥12 years) 5, 6, 7

The American Academy of Dermatology recommends never abruptly discontinuing high-potency corticosteroids due to the risk of severe rebound flare, and instead transitioning to alternative maintenance therapy (vitamin D analog, calcineurin inhibitor, or weekend-only corticosteroid) 1, 2
The American Academy of Dermatology advises against using systemic corticosteroids, as they can precipitate or worsen psoriasis flares upon discontinuation, and avoiding salicylic acid with calcipotriol, as acidic pH inactivates calcipotriol and reduces effectiveness 3